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Abstract 
Until recently, the therapeutic effects of furocoumarins and furochromones plus UV-A light were thought o be due to their ability to 
form photoadducts with DNA in the cell nuclei; now it appears that membrane effector systems may be involved as targets. Here we show 
that in HeLa cells khellin at 1 and 5 tzM final concentration, in combination with UV-A light, inhibits NaF-stimulated adenylyl cyclase 
activity and Pertussis Toxin (PT)-catalyzed ADP-ribosylation of a-subunits of inhibitory guanine nucleotide regulatory proteins (Gi) and 
increases GTPase activity. In the same experimental conditions, 8-methoxypsoralen (8-MOP), either alone or plus UV-A, does not affect 
adenylyl cyclase and GTPase activities. Our results uggest that in HeLa cells, through an interaction with a receptor and the mediation of 
Gi proteins, the adenylyl cyclase system is a target for khellin but not for 8-MOP. 
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I. Introduction 
Since the 1970s, PUVA (Psoralen plus UV-A) therapy 
has been used for a number of skin diseases (e.g., psoriasis 
and vitiligo) [1]. More recently, psoralens (also called 
furocoumarins) have been employed as photochemoprotec- 
tive agents against the risk of UV-B exposure [2] and in 
photochemical decontamination of blood products [3]. Fi- 
nally psoralens, used in 'photopheresis' - - an extracorpo- 
real photochemotherapy - -  act as immunological modi- 
fiers against disorders of circulating T-cells [4]. 
The therapeutic action of psoralens is widely ascribed to 
the formation of DNA-psoralen photoadducts [5]. How- 
ever, the effects of the psoralen-membrane phospholipid 
reaction [6] and the modulation of PLC, adenylyl cyclase 
[7] and the immune system [8] following PUVA treatment 
strongly indicate the interactions of psoralens with cell 
membranes and suggest hat these structures represent an 
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important arget involved in their clinical effectiveness. All 
these experimental observations are further supported by 
the discovery of a membrane receptor for 8-MOP [9] and 
by the demonstrated biological activity of psoralen ana- 
logues deprived of their ability to form the traditional 
DNA cross-linked double photoadducts [10] Moreover, 
there is evidence that 8-MOP, either alone or in combina- 
tion with UV-A light, modulates gene expression [11], and 
that UV light triggers a number of signalling events at the 
plasma membrane in mammalian cells (including those 
that ultimately lead to an increase in gene expression) by 
modulating transcription factor activity [12-14]. 
For a better understanding of the molecular mechanism 
of action, we have studied, in HeLa cells, the behaviour of 
adenylyl cyclase, PT-catalyzed ADP-ribosylation and the 
GTPase activity of GTP binding proteins related to the 
action of adenylyl cyclase, under the effects of two differ- 
ent photochemotherapeutic agents: 8-MOP (commonly 
used in PUVA therapy), which is a linear psoralen very 
active in photobinding to DNA and cell membrane pro- 
teins and phospholipids [6]; and khellin, a natural 
furochromone structurally related to psoralens but a poor 
producer of photoadducts o DNA [ 15-17]. 
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2. Materials and methods 
2.1. Cell treatment 
stimulated conditions was measured with the commercially 
available radio-immunoassay kit (Cyclic [3H]AMP assay 
system) of Amersham. 
HeLa cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum, 
100 U/ml  penicillin G and 100 mg/ml streptomycin, at
37°C in a controlled humidified incubator in 5% CO 2. 
4. 10 6 cells were placed on 9 cm plastic Petri dishes and 
after 72 h the monolayers of HeLa cells were washed 
twice with serum-free DMEM and incubated again at 37°C 
for 30 min in the same medium without or with 8-MOP or 
khellin (1 and 5/zM, final concentrations). Stock solutions 
of the two drugs were prepared by dissolving them in 
absolute thanol (5 • 10 -2 M) and dilutions with serum-free 
DMEM were made prior to their addition to the cells. 
After 30 min, a series of cell culture dishes was kept in the 
dark, while the others, with the top removed, were irradi- 
ated with UV-A light (320-400 nm) with a peak emission 
at 366 nm. The UV-A source consisted of four black-light 
tubes (purchased from Helios Italquarz srl; Milano) placed 
20 cm above the culture dishes. The incident light was 
measured with a Centro UVMeBger'~it OSRAM Interna- 
tional Light UV-radiometer. In all experiments cells were 
exposed to 2 J /cm 2. The intensity of the UV-A light used 
corresponds tothat employed for therapeutic purposes (and 
which provides a satisfactory effect). Indeed, unpublished 
results have shown that lower intensities (0.5-1.5 J /cm 2) 
lead to a lesser effect, while higher intensities (> 2 J /cm 2) 
elicit phototoxic side effects. 
During the time of irradiation (10 min), the cells were 
covered with phosphate-buffered saline (PBS). Controls 
are the cells without drugs and without irradiation. After 
the exposure, the cells were used for the preparation of 
membranes. 
The viability of the cells, as assayed by Trypan blue 
exclusion (95% under control conditions), was unaffected 
by both drugs studied and by UV-A irradiation. 
2.2. Membrane preparation 
Cells were harvested by scraping in ice-cold PBS and 
then pelleted at 3000 rpm for 15 min at 4°C. The cells 
were placed for 5 min in hypotonic buffer consisting of 50 
mM Tris-HC1 (pH 7.6) and homogenized using a Dounce 
glass-glass (35 strokes). After centrifugation at23 000 × g 
for 20 min at 4°C, the pellet was resuspended in 50 mM 
Tris-HC1 (pH 7.6) to yield a membrane fraction containing 
2 mg of proteins per ml as determined by the method of 
Bradford [18]. The fraction was used promptly (to evaluate 
adenylyl cyclase activity) or after storage at -70°C (to 
evaluate ADP-ribosylation and GTPase activity). 
2.3. Adenylyl cyclase assay 
Adenylyl cyclase activity in basal and NaF (10 mM)- 
2.4. ADP-ribosylation 
ADP-ribosylation of HeLa membranes was induced by 
PT. Prior to its addition to membrane preparations, PT (1 
mg/ml) was activated by incubation in 20 mM dithio- 
threitol (DTI') at 30°C for 30 min. The HeLa membranes 
(50 /xg of proteins) and ROS (rod outer segments) mem- 
branes (20/xg) used as an internal control, were incubated 
at 37°C for 1 h with and without PT (5 /xg/ml) in 150/~1 
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Fig. 1. (A) Effect of 8-MOP, UV-A light and a combination of the two on 
adenylyl cyclase activity. Cell cultures were treated with the indicated 
concentrations of 8-MOP with or without UV-A light (2 J/cm2). Mem- 
branes were prepared from control and treated cultures and assayed for 
adenylyl cyclase activity as described in Section 2. The specific activities 
of basal and NaF-stimulated adenylyl cyclase are reported. Values repre- 
sent the mean + S.E. of 12 measurements (4 assays in 3 separate xperi- 
ments). NS: p > 0.05, compared to control. (B) Effect of khellin, UV-A 
light and a combination of the two on adenylyl cyclase activity. Cell 
cultures were treated with the indicated concentrations of khellin with or 
without UV-A light (2 J /cm2). Membranes were prepared from control 
and treated cultures and assayed for adenylyl cyclase activity as described 
in Section 2. The specific activities of basal and NaF-stimulated adenylyl 
cyclase are reported. Values represent the mean-I-S.E, of 12 measure- 
ments (4 assays in 3 separate xperiments). *" p < 0.01 and *""  
p < 0.001, compared to control. 
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of a reaction mixture containing: 70 mM Tris-HC1 (pH 
7.4), 0.7 mM ATP, 0.07 mM GTP, 17 mM thymidine, 
1.12 /zM [32 P]NAD. The ADP-ribosylation was started by 
the addition of [32p]NAD. The samples (in duplicate) were 
incubated at 30°C for 60 min and the reaction was termi- 
nated by centrifugation for 3 min at 10000 rpm. The 
radiolabelled membranes were washed with 200 /zl of 50 
mM Tris-HCl (pH 7.5) and then centrifuged at 10000 rpm. 
The pellet was dissolved in 30 /zl of Laemmli sample 
buffer and heated for 3 min in a boiling water bath. 
The labelled proteins were separated using 12% SDS- 
polyacrylamide gels [19]. After electrophoresis the gels 
were placed in a solution of 5% glycerol, 10% methanol 
and 5% acetic acid for 2 h and then enveloped. The bands 
labelled with 32p were visualized and quantified by Phos- 
phorlmager 400 A (Molecular Dynamics, Sunnyvale, CA, 
USA). 
2.5. GTPase assay 
GTPase assay was performed by measuring the release 
of 32p from [ ~-32 P]GTP essentially as described by Cassel 
[20]. The HeLa cell membranes (10-20 /zg) were incu- 
bated at 37°C for 10 min in 100 /~1 of reaction mixture 
containing 50 mM imidazole HC1 buffer (pH 6.7), 0.25 
/zM [32p]GTP (30 Ci /mmol) ,  5 mM MgC12, 0.2 mM 
5'-adenylyl imidodiphosphate (App(NH)p), 0.1 mM ATP, 
0.1 mM EGTA, 2 mM mercaptoethanol, and ATP-gener- 
ating system consisting of 3 units of creatine phosphoki- 
nase and 2 mM creatine phosphate. The assay was begun 
by addition of [,/-32p]GTP to the mixture which was then 
incubated for 30 min at 37°C. The reaction was stopped by 
addition of 0.5 ml of a 5% suspension of Norit A in 20 
mM phosphate buffer (pH 7). The mixture was centrifuged 
at 12000 rpm for 5 min at 4°C and the 32p in the clear 
supernatant (200 /xl) was measured. 
The blank value, due to contamination of the substrate 
by 32p and non-enzymatic hydrolysis of 32p during the 
assay, was less than 1% of the total radioactivity in the 
reaction mixture and it was subtracted from all data. 
2.6. Statistical analysis 
Results are expressed as mean + S.E. Data were ana- 
lyzed using Student's t-test; p < 0.05 was considered sta- 
tistically significant. 
3. Results 
3.1. Inhibition of adenylyl cyclase in membranes from 
HeLa cells treated with kheUin in the dark and plus UV-A 
light 
Fig. 1 shows that UV-A light alone does not modify 
adenylyl cyclase. Similarly 8-MOP, at 1 or 5 /~M final 
concentration, fails to affect either basal or stimulated 
adenylyl cyclase activity in any of the experimental condi- 
tions (Fig. 1A). Although cell treatment with khellin (alone 
or with UV-A) does not significantly alter basal adenylyl 
cyclase, the combination of khellin and UV-A markedly 
decreases the NaF-stimulated enzymatic activity; at the 
higher concentration (5 /zM), the inhibitory effect is more 
evident (Fig. 1B). Stimulated adenylyl cyclase activity is 
also decreased, to a lesser degree, by khellin 1 and 5 /zM 
alone. 
3.2. Cell treatment with khellin or 8-MOP, alone and plus 
UV-A light, inhibits the subsequent PT-dependent ADP- 
ribosylation of membrane Gi a 
In order to investigate whether the inhibition of adeny- 
lyl cyclase by khellin is through Gi proteins [21], we 
evaluated the PT-dependent ADP-ribosylation of mem- 
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Fig. 2. SDS-polyacylamide gelelectrophoresis of HeLa cell membranes after [32 P]ADP-ribosylation byPT. Membranes (50/zg) obtained from HeLa cells 
previously treated as reported in Section 2, were incubated at37°C for 1 h with PT in 150 /zl of a reaction mixture containing 1.12 /zM [32p]NAD. The 
radiolabeled proteins were analysed by Phosphorlmager 400. Panel A: control (lane 1), UV-A light (lanes 2 and 3), 1 /zM 8-MOP (lane 4), 1 /zM 8-MOP 
plus UV-A light (lane 5), 5/zM 8-MOP (lane 6), 5/zM 8-MOP plus UV-A light (lane 7), without PT (lane 8),ROS membranes (lane 9). Panel B: control 
(lanes 1 and 2), UV-A light (lane 3), 1 /zM khellin (lane 4), 1 /zM khellin plus UV-A light (lane 5), 5/zM khellin (lane 6), 5/zM khellin plus UV-A light 
(lane 7), without PT (lane 8), ROS membranes (lane 9). Similar esults were obtained in two other experiments. Quantification f the radioactivity of
individual band from three experiments is given in Fig. 3A and 3B. 
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Fig. 3. (A) Effect of UV-A light, 8-MOP and a combination of the two on 
PT-dependent ADP-ribosylation of the ~-subunit of Gi in HeLa cell 
membranes. The amount of ADP-ribosylation measured with 'Imag- 
eQuant' is expressed as the percentage of the control value obtained 
without UV-A light and drugs (mean values+S.E.). * * p < 0.01 and 
• * * p < 0.001, compared to control. (B) Effect of UVA light, khellin 
and a combination of the two on PT-dependent ADP-ribosilation of the 
~-subunit of Gi in HeLa cell membranes. The amount of ADP-ribosyla- 
tion measured with 'ImageQuant' is expressed as the percentage of the 
control value obtained without UV-A light and drugs (mean values ± S.E.). 
• * p < 0.01 and * * * p < 0.001, compared to control. 
brane Gi a. This assay is useful for monitoring the degree 
of ligand-induced G-protein activation [22,23]. 
Membranes, obtained from HeLa cells previously treated 
with drugs and UV-A light, as indicated in Section 2, were 
incubated with [32p]NAD and PT. Gel electrophoresis 
followed by Phorphorlmager analysis resulted in the pre- 
dominant labelling of protein band with a molecular weight 
of 41 kDa (Fig. 2). Based on known specificity of the 
toxin and on electrophoretic mobility of ADP-ribosylated 
product he substrate is considered to be the a-subunit of 
Gi a. Without PT no radiolabelling was observed (lanes 8 
in Fig. 2). The amount of [32P]ADP-ribosylation was 
determined by measuring the radioactivity of invidual bands 
in three experiments with 'ImageQuant'. Exposure to 
UV-A light alone decreases ADP-ribosylation but not sig- 
nificantly (Fig. 3). A significant inhibitory effect of 8-MOP 
on ADP-ribosyl-transferase activity is detectable only at 
the 5 /zM concentration f the drug plus UV-A radiation 
(Fig. 3a). In contrast, khellin inhibits the enzyme ven in 
dark conditions; UV-A light enhances the extent of inhibi- 
tion, which reaches a maximum with the combination of 
khellin 5 #M and UV-A (Fig. 3b). 
3.3. Increase of GTPase activity by cell treatment with 
khellin alone and plus UV-A light 
Fig. 4a shows that GTPase activity is not affected by 
UV-A radiation or 8-MOP alone, or by a combination of 
the two. However, a significant increase in the enzymatic 
activity is seen when cells are treated with khellin, both 
alone and in combination with UV-A light, which is 
maximal at the higher concentration f the drug (Fig. 4b). 
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Fig. 4. (a) Effect of 8-MOP, UV-A light and a combination of the two on 
GTPase activity. Membranes were preparated as in Fig. 1A, and were 
assayed for GTPase activity as described in Section 2. Specific activity of 
GTPase is reported. Values represent the mean+S.E., compared to 
control. (B) Effect of khellin, UV-A light and a combination of the two 
on GTPase activity. Membranes were preparated as in Fig. 1A, and were 
assayed for GTPase activity as described in Section 2. Specific activity of 
GTPase is reported. Values represent the mean+SE. * * p < 0.01 and 
p < 0.001, compared to control. 
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4. Discussion 
Relationships between adenylyl cyclase and UV-A, 
PUVA or psoralen alone have been detected in various cell 
types or tissues and in different experimental conditions 
[7]. 
Our studies indicate that, in HeLa cells, 8-MOP alone 
or in combination with UV-A light does not affect basal or 
stimulated adenylyl cyclase, suggesting that its main mode 
of action is the known effect of this psoralen on the EGF 
receptor [11,24] which is expressed in HeLa cells [9]. 
Although susceptible to interact with the 8-MOP receptor 
because of its structural similarity to 8-MOP, khellin (at 1 
and 5 /zM), both alone and in combination with UV-A 
light, inhibits NaF-stimulated adenylyl cyclase activity, but 
in the same experimental conditions, does not affect basal 
adenylyl cyclase. These results suggest hat khellin does 
not interact with the catalytic subunit of adenylyl cyclase 
which is the reflection of basal enzyme activity and led us 
to investigate whether the inhibitory effect of khellin might 
be due to a receptor-coupled phenomenon probably requir- 
ing GTP-binding proteins. 
It is well known that Gi protein mediates the inhibition 
of adenylyl cyclase in numerous cell types. Activation of 
heterotrimeric G protein by an agonist-occupied receptor 
results in an exchange of bound GDP for GTP in the 
ce-subunit which then dissociates from the /3-~ subunits' 
complex [21]. PT ADP-ribosylates only the unstimulated 
intact heterotrimeric G protein, whereas the free c~-subunit 
is no longer susceptible to ADP-ribosylation [22,23]. We 
have demonstrated that cell treatment with khellin and 
UV-A light inhibits ADP-ribosylation of c~-subunits of Gi 
catalyzed by PT and this inhibition is correlated with the 
inhibition of adenylyl cyclase activity. Thus our results 
indicate that khellin can trigger a dissociation of the 
a-subunit resulting in decreased ADP-ribosylation of Gi. 
The inhibitory effect on ADP-ribosylation exerted by 
cell treatment with 8-MOP (at its higher concentration) i  
combination with UV-A light seems to be due to an 
aspecific interaction with the membrane, since it is not 
related to any effect on adenylyl cyclase activity. Support 
for this hypothesis comes from the experiments showing 
that cell treatment with 8-MOP, both alone and in combi- 
nation with UV-A light, does not affect GTPase activity, 
which plays a central role in the phenomenon of receptor 
coupling with adenylyl cyclase [21]. In contrast, cell treat- 
ment with khellin increases GTPase activity both in the 
dark and plus UV-A light. It is therefore probable that a Gi 
protein is involved in the inhibitory effect of khellin on 
adenylyl cyclase activity. 
Concerning HeLa cells, the following concluding re- 
marks can be made. Khellin, a very weak DNA-photobind- 
ing compound, is able to exert its phototherapeutic activity 
probably on account of its effect on the adenylyl cyclase 
membrane system by means of inhibitory guanine nu- 
cleotide regulatory proteins. The receptor presumed to be 
involved in the process has no affinity (or the affinity 
cannot be detected) for 8-MOP which seems to act by 
means of other membrane sites [6]. 
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